Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
Synthesis and biological assessment of novel analogues of N-hydroxyarginine: potential as reno-selective vasodilatation for acute renal failure.
Webb, David
(Principal Investigator)
Megson, Ian
(Co-investigator)
Deanery of Clinical Sciences
Centre for Cardiovascular Science
University of Edinburgh
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/10/03
→
30/09/07
Funding
UK-based charities:
£435,126.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Prodrug
Pharmacology, Toxicology and Pharmaceutical Science
100%
Nitric Oxide Donor
Pharmacology, Toxicology and Pharmaceutical Science
100%
Gamma Glutamyltransferase
Pharmacology, Toxicology and Pharmaceutical Science
100%
Nitric Oxide
Pharmacology, Toxicology and Pharmaceutical Science
50%
Kidney Injury
Pharmacology, Toxicology and Pharmaceutical Science
50%
Research output
Research output per year
2013
2013
2013
1
Article
Research output per year
Research output per year
A new class of NO-donor pro-drugs triggered by gamma-glutamyl transpeptidase with potential for reno-selective vasodilatation
Zhang, Q., Kulczynska, A.,
Webb, D. J.
, Megson, I. L. & Botting, N. P.,
18 Feb 2013
,
In:
Chemical Communications.
49
,
14
,
p. 1389-1391
3 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Prodrug
100%
Nitric Oxide Donor
100%
Gamma Glutamyltransferase
100%
Nitric Oxide
50%
Kidney Injury
50%